UK regulator approves first generic raltegravir drugs for HIV
Drug Discovery World
JULY 23, 2024
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved the first generic raltegravir drug to treat adult and paediatric HIV patients who weigh at least 40kg. The drug is a generic version of Merck’s Isentress and is manufactured by Lupin Healthcare and Zentiva Pharma.
Let's personalize your content